Upload
others
View
3
Download
0
Embed Size (px)
Citation preview
Grand RoundsAnthony DeWilde, OD
1
Patient 1
72 year old African American male
Blur OD x 3 months
Last eye exam 10 years ago
2
Ocular History
Mixed Mechanism Glaucoma
S/P LPI OU
Was on Xalatan qhs OU – no longer taking
Blunt trauma OD
3
Medical History
HTN
Anemia
CVA x 2
Hyperlipidemia
Kidney Disease
4
Medications
Amlodipine
Atenolol
HCTZ
Simvastatin
ASA
5
Exam
BCVA OD: 20/320, OS: 20/25
+APD OD
Anterior Segment Normal
Except Mild NS OU
6
Exam
Gonio: Narrow with old PAS
S/P LPI OU
IOP 14/14
7
Posterior Segment
Optic Nerve
0.75 OD - Pallor
0.90 OS
No maculopathy
No vasculopathy
Peripheral retina normal
8
Pallor Vs. Excavation9
Pallor Vs. Excavation10
11
12
13
14
Differential
Glaucoma
Other Optic Atrophy
Traumatic
Compressive
Inflammatory
15
What Tests?
VF?
OCT?
Imaging?
16
VF - OD17
VF - OS18
New Differential
Glaucoma
Compressive Lesion
CVA
19
MRI20
MRI21
Diagnosis
Pituitary Adenoma – 2.5 x 1.6 cm
22
Treatment
Monitor only
Due to other health factors
Patient reports vision is fine
23
Pituitary TumorsHormone-Producing
Prolactinoma
Growth Hormone Secreting
ACTH Secreting (Cushing’s)
Hormone Inactive
Size
24
Treatment
Goals
Normalize hormone levels
Pituitary gland function
Reduce signs/symptoms of tumor
25
Treatment
Medication (Micro)
Bromocriptine – Dopamine agonist
Hormone stabilization
26
Treatment
Surgery (Macro)
Transsphenoidal
Transcranial
27
Treatment
drarunlnaik.com
28
Take Home
Check both eyes
Pituitary vs. Glaucoma
Pallor vs. Excavation
29
Patient 2
72 YO Hispanic Male
Blur OD/OS - Worse at night
IOP 16/14
BCVA 20/40, 20/30
30
Removal of tumor on “Left Optic Nerve” x 1990
31
Anterior Segment Unremarkable except
2+ NS OU
32
33
34
Anterior Segment Unremarkable except
2+ NS OU
35
Anterior Segment Unremarkable except
2+ NS OU
36
Bitemporal Hemianopsia
Old or new??
37
Patient 1.138
Old or new??
39
Old or new??
40
Followed by Endocrinology
Tumor resected
Cataract removed
41
“The best place to find a brain tumor is a glaucoma clinic”
42
Patient 3
59 Y/O White Male
Medical HX
HTN, COPD, Arthritis, Kidney Failure
Peripheral Vascular Disease, Anemia
Carotid Artery Stenosis, Hyperlipidemia
Amputee – Bilateral
43
Medications:
HCTZ
Norvasc
Metoprolol
Lisinopril
Simvastatin
Warfarin
44
Examination
Blur for 1 month
BCVA: 20/40 OD, 20/100 OS
+ APD OS
IOP 6/10
Anterior Segment:
Mild Cataract OS>OD
45
Posterior Segment
Mild artery attenuation
Mild ONH nerve pallor
Retina appears perfused
46
47
48
49
50
Lessons Learned
“Classic” Presentation of CRAO
Giant Cell Arteritis
Consider Ophthalmic Artery
Neovascularization
Risk to Brain and Heart
Have a Heart
51
Lesson #1
“Classic” Presentation of CRAO
Presentation of CRAO after reperfusion
52
53
54
55
Differential Diagnosis
Central Retinal Artery Occlusion
Ophthalmic Artery Occlusion
Ocular Ischemic Syndrome
Giant Cell Arteritis
56
Lesson #2
5-15% of CRAOs are from Temporal Arteritis
57
Additional Tests
ESR = 31 (slightly elevated)**
CRP = 0.5 (normal)
CBC = Abnormal RBC, HCT, HGB (Anemic)**
Carotid Doppler
Carotid Angiography
58
Carotid Doppler ResultsStent in the right distal common carotid artery
Interval occlusion of the common carotid artery
Degree of stenosis in the right internal carotid artery cannot be measured
Low flow to internal carotid
59
Follow – Up
1 month later (2 months after start of blur)
Very sluggish pupil and VA Hand Motion
60
Follow – Up
5 month follow-up:
Dense, hypermature cataract
Neovascularization of the Iris
Neovascularization of the Angle 360 degrees
61
Lesson #3
Consider an Ophthalmic Artery Occlusion/OIS
62
Lesson #4
CRAO can develop anterior segment NV
63
Treatment
Avastin for Neovascularization
Didn’t help regress NV
Otherwise, monitor only
Goal of this eye is no pain
Still weighing Risk/Benefit of Cataract Extraction
64
Lesson #5
Increased risk for CVA/MI
Risk for Heart Attack is greater
65
Lesson #5
AHA and ASA recommend urgent referral
CRAO/BRAO requires ER visit
66
Lesson #5
79% OF CRAO HAD ACUTE SYSTEMIC CHANGE
MEDICATION CHANGE 92%
CAROTID DISEASE 37%
CVA 37%
ECHOCARDIO 20%
Am J Ophthalmol 2018;196:96-100
67
Lesson #5
Amaurosis Fugax requires ER visit
68
Lesson #569
Lesson #5
Asymptomatic retinal emboli??
70
Lesson #5
TIA used to mean timing
TIA now means location
Eye is part of the Central Nervous System
71
Lesson #6
Compassion
72
Patient 4
30 year old white female
CC: Headache and vision loss
H/O vision loss OD, diplopia
Improved now
73
Currently on
Diamox
Butalbital
74
BCVA 20/40 OD, CF OS
APD OS
Confrontation VF Full OD, Limited OS
Color Vision: 10/10 OD, 1/10 OS
Anterior Segment Unremarkable
75
76
77
Differential
Papilledema
Intracranial Hypertension
Malignant Hypertension
Space Occupying Lesion
Cerebral Venous Thrombosis
78
Inflammatory
Infectious vs Non-infectious
ONH Drusen
Uveitis
Optic Neuritis??
79
62 inches (157 cm)
462 lbs (210 kg)
BMI 85
BP: 110/80
80
MRI Normal
LP – 490 then 310
Normal opening pressure up to 250 mm H2O
in obese patients
81
1 Month Later…
BCVA 20/20 OD, 20/200 OS
S/P VP shunt x 1 month
On Diamox still
OD swollen, OS swollen and atrophic
82
83
84
8 years later…
no Diamox
20/20 OD - minimal VF loss
20/200 OS - stable VF loss
85
86
87
Why is one eye 20/20 and the other 20/200?
88
Idiopathic Intracranial Hypertension
Old names:
'Benign' Intracranial Hypertension
Pseudotumor Cerebri
89
Idiopathic Intracranial Hypertension
1 in 100,000 people
Young women
10% overweight = 13x more likely
90
Idiopathic Intracranial Hypertension
Causes are unknown
91
Idiopathic Intracranial Hypertension
Symptoms are varied
Asymptomatic
Headache
Blurred vision
Diplopia
Nausea
92
Idiopathic Intracranial Hypertension
Diagnosis of exclusion
MRI/MRA/MRV
Lumbar Puncture
Blood Pressure
93
Idiopathic Intracranial Hypertension
Treatment
Weight loss
Diamox
VP shunt
94
Patient 5
58 year old Black Male
Consult for Transient Vision Loss
Pain behind eyes
Photophobia
95
Currently inpatient
+DM
+HTN
+Kidney Disease
96
VAcc 20/20 OD/OS
Anterior Segment healthy
97
98
99
100
Malignant Hypertension
101
Malignant HTN
BP > 180/120
Kidney Disease
Adrenal Tumor
Illicit drug use (i.e. cocaine)
Collagen Vascular Disease
102
Malignant HTN
Headache
Blurred Vision
Shortness of Breath
103
Malignant HTN
This is a medical emergency
104
Patient 6
39 Year Old White Male
Consult for vision loss OU
105
Vision loss gradual
20/200 OD/OS
Mild APD OS
106
History of Testicular Cancer
Patient has slow gait
VERY!! Sick Appearance
107
Anterior Segment Normal
IOP 22/22
108
109
110
111
112
Toxic/Nutritional Optic Neuropathy
113
Lack of B Vitamins/Folic Acid
Bariatric Surgery
Malnutrition
Alcoholism
114
Cuban Epidemic Optic Neuropathy
American Journal of Ophthalmology
Vol 193. September 2018. Pages xix-xxvii
115
Management
Find source
Vitamin B supplement
116
Patient 7
74 YO WM
C/O Blur
No pain or discomfort
117
BCVA 20/40 OD/OS
Anterior Segment normal except
2+ NS OU
118
Diagnosis: Cataract
119
But…what about this?
120
Patient 14121
Nevus OD - 2007
122
Fast forward to 2013
123
124
Patient 14125
126
127
Small Choroidal Melanoma
128
Risk Factors
1. Tumor thickness greater than 2.0 mm
2. Subretinal fluid
3. Visual symptoms
4. Orange pigment
5. Posterior tumor margin touching the disc
6. Lack of drusen
129
Shields CL, et al. Risk factors for growth and metastasis of small choroidal melanocytic lesions. Ophthalmology 1995;102:1351-1361.
The Collaborative Ocular Melanoma Study Group. Factors predictive of growth and treatment of small choroidal melanoma. Arch Ophthalmol 1997;115:1537-1544.
130
Treated with Radioactive Plaque Therapy
Developed Radiation Retinopathy
Optic nerve edema, Macular edema
Treated with Anti-VEGF
131
What is the likelihood of Nevus changing to Melanoma?
Nevus = 3-20% of population
Melanoma = 6 per 1 million
About 15,000 nevi per 1 melanoma
132
COMS
Small Melanoma
< 2.4 mm height
5-16 mm diameter
133
COMS
Small Melanoma
5-year all cause mortality = 6%
134
COMS
Medium Melanoma
2.5–10 mm height
≤16 mm diameter
135
COMS
Medium Melanoma
Mortality with enucleation = 19%
Mortality with brachytherapy = 18%
136
COMS
Large Melanoma
>10 apical height
>16 mm diameter
137
COMS
Large Melanoma
Mortality with enucleation = 43%
Mortality with enucleation and pre-op radiation = 38%
138
COMS
COMS excluded tumors near optic nerve
139
COMS
New evidence supports using Low-dose Iodine-125 plaque brachytherapy
140
Meta-analysis
5-year all cause mortality
Large = 53% Medium = 32% Small = 16%
141
Radiation Retinopathy
Exposure to External Beam Radiation or Brachytherapy
Usually within 6 months to 3 years
Can happen 15 years later
142
http://www.med.unc.edu
143
Radiation Retinopathy
Signs
Retinopathy similar to DM
Macular edema
Optic nerve edema
144
Radiation Retinopathy
Symptoms
Typically asymptomatic
Can develop floaters and/or visual acuity loss
145
Radiation Retinopathy
Treatment
Monitor
Laser (focal/grid or PRP)
Intravitreal triamcinolone
Intravitreal Anti-VEGF
146
Patient 8
52 year old Black Male
CC: Working on car. Got something in eye
Blur, photophobia, pain
147
VA: 20/40, CF
A/C: 3+ Cells
Vitreous: 3+ Cells
148
149
150
Penetrating foreign body
Corneal and iris laceration noted on Slit Lamp
151
Same day retinal surgery
Extra capsular cataract extraction
S/P PPV
Patient left aphakic
152
Now S/P Tube Shunt
Secondary IOL
20/50
153
154
155
Patient 9
64 year old WM
CC: Blurred vision OS - present since last year
+DM
BCVA: 20/25 OD, 20/40 OS
Anterior Segment Unremarkable
156
157
158
Impending Lamellar Macular Hole
159
2011 160
2016 161
162
Patient 8
74 Y/O Hispanic Male
CC: Blurry vision
+DM, +Cataract
BCVA: 20/40 OD, 20/25 OS
163
164
Lamellar Macular Hole
165
Lamellar Macular Hole
Not full thickness
Atypical borders
“Inverted Anvil”
166
Lamellar Macular Hole
Acuity typically better
Difficult to treat
May be more selective on when to treat
167
Patient 10
65 Y/O WM
Progressive blurring
Affecting golf, reading
168
07/2014
20/20 OD, 20/25 OS
Anterior segment: Mild NS OU
Mild ERM OU
169
11/2014
20/20 OD, 20/50 OS
Mild ERM OD
Moderate ERM OS
170
02/2015
20/30 OD, 20/50 OS
Moderate ERM/VMT OD
Moderate ERM OS
171
08/2015
20/50 OD, 20/200 OS
Moderate ERM/VMT OD
Moderate ERM OS
172
173
174
Refer to Retinal Specialist
Vitrectomy and ERM Peel OS (20/200)
175
01/2016
20/30 OD (Stable)
20/40 OS (Was 20/200)
States vision still distorted
Mild Cataract OU
176
177
178
179
180
01/2018
20/25 OD (Stable)
20/25 OS (Was 20/200)
S/P PCIOL OU
181
ERM
Macular Pucker
Creates traction of retina
Can induce edema (typically cystic)
182
183
184
185
186
ERM
Blur
Distortion
Metamorphosis
Range of acuity (20/20 - 20/400)
How many progress?
187
ERM
Typically asymptomatic
If acuity reduced to < 20/40, treat
ILM peel
ERM peel
Vitrectomy
**Cataract Surgery
188
Patient 11
75 Y/O WM
CC: Blur OU
S/P PCIOL OU
COPD, DM, HTN
Anterior segment unremarkable
189
BCVA: 20/50 OD, 20/100 OS
190
191
192
Bilateral macular hole
Patient elected to not have treatment
COPD
193
Macular Hole
Full thickness retinal break
Acuity typically 20/100-20/200**
194
Acuity?195
196
197
Macular Hole
Treatment
Vitrectomy
Broad ILM peel
Fluid gas exchange
198
Macular Hole
Complications
Cataract
Face down position
Lack of closure
199
Macular Hole
ILM Peel with No Face-Down Positioning
Ophthalmology 2013;120:1998-2003
200
Macular Hole
68 patients with idiopathic full thickness macular hole
Vitrectomy, ERM/ILM peel, SF6
Reading position post-op (3-5 days)
201
Macular Hole
100% closure
Mean pre-op 20/100
Mean post-op 20/40
No complications
202
OCT
Historically macular problems diagnosed by
Fundus Appearance
Visual Acuity
203
OCT
OCT changed accuracy of diagnosis
Better able to give prognosis
Better guidance for treatment
Better post-op monitor
204
Patient 12
92 YO WM
CC: “Needs Driver’s Form Filled Out”
205
Ocular History
Cataract Surgery
Glaucoma Suspect
206
Medical History
Hypertension
Colon Cancer
Lung Metastasis?
207
VAcc 20/20, 20/25
Anterior Segment healthy except
208
209
210
~2MM amelanotic cystic growth
Pushing iris back
Gonio: 2 Feeder vessels
211
Posterior segment normal - no tumor
Large C/D ~ 0.6 OU
IOP 16/18
212
Diagnosis: Invasive Carcinoadenoma
Metastasis from Colon
Likely Metastasis to lung
213
Treatment: Hospice
214
Returned to clinic 2 months
New Hyphema
Stabilized
Goal is no pain
215
If eye tumor
Need to consider ophthalmic prognosis
Need to evaluate for metastasis
216
Patient 13
54 YO WM
Blur
Diplopia
217
BCVA 20/25, 20/20
EOM: Poor abduction OS
Not comitant
Anterior Segment Normal
No APD
218
219
220
Bilateral Optic Nerve Edema
MRI
Lumbar Puncture
Blood Pressure
221
MRI - Inconclusive
Blood Pressure - 145/80
LP - Opening pressure Day 1 = 43
Day 2 = 36
+WBC
222
LP Cytology - cancer cells
Diagnosis = Leptomeningeal Carcinomatosis
223
Metastasis from esophageal cancer (rare)
More common from breast, lymphoma, leukemia
224
Patient treated with systemic chemotherapy
Died 6 months later
225
Patient 14
72 year old male
C/O Red Eye x 1 day
226
227
VAsc 20/20
SLEX Normal - except conjunctiva OS
IOP 32/32
Gonio Narrow - no PAS
228
229
230
231
232
233
234
Patient 14
Glaucoma is usually ASYMPTOMATIC
Don’t brush off sub-conjunctival heme
235
Patient 15
58 year old African American Male
C/O blur at near
236
Myopic
20/20 OD, 20/25 OS
Anterior Segment Unremarkable
No APD
IOP 17/17
237
238
239
240
241
Diagnosis?
242
Solar Maculopathy
243
Solar Maculopathy
Thermal Burn
Pscyh Diagnosis
Eclipse
Drugs
244
Solar Maculopathy
Adjustment Disorder
Alcohol Abuse
Inadequate Housing
Depressive Disorder
Tobacco Dependence
245
246
247
248
Solar Maculopathy
No ocular treatment - non progressive
Mental health referral?
249
Patient 16
42 y/o white male
CC: Spots in vision OS for 7 days. Spots don’t move
No pain or discomfort
No family history
No ocular history
250
BCVA
20/30
20/400
EOM - Full
Confrontation - Full
P + RXN - No APD
251
IOP 15/15
Anterior Segment Normal
Retina:
White lesions throughout retina OS>OD
252
253
254
255
256
257
258
Purtscher’s Retinopathy (or Purtscher’s Like Retinopathy)
In a patient with Severe Alcoholism
Recent Acute Pancreatitis
259
Refer to:
Retina
Rehab
260
Purtscher’s Retinopathy
Purtscher’s Retinopathy is rare
Often associated with trauma
60% bilateral
261
Purtscher’s Retinopathy
Can be associated with other conditions:
Acute pancreatitis (100% bilateral)
Connective tissue disorder
Childbirth
Renal disease
262
Purtscher’s Retinopathy
Purtscher flecken are pathognomonic findings
Polygonal areas of retinal whitening with a clear demarcating line
263
264
Purtscher’s Retinopathy
No known successful treatment
Often try IV steroids
265
Purtscher’s Retinopathy
Patient unlikely to recover visual acuity
Especially if nonperfusion
266
Patient 17
72 year old White Male
History of “burst blood vessel” OS
OD normal
Establishing care at VA
267
VA: 20/20 OD, 20/400 OS
Anterior Segment Normal
ACIOL OD
PCIOL OS
268
EOM, IOP, Confrontation normal
269
270
271
Differential
BRVO
HRVO
AMD
Macroaneurysm
272
We called it wet AMD
Were we right?
273
274
Macroaneurysm
Usually asymptomatic
Threats to vision: heme at macula, macular edema
275
Macroaneurysm
Can be monitored if no threat to vision
Treated with laser photocoagulation
Anti-VEGF
276
Patient 18
55 YO WF
C/O Blur OS
Pain on eye movement
Headache OS
277
History
Strabismic Amblyopia OD
Normal health
278
Came to KCVA - transfer
Labs normal except Lyme
Normal MRI
279
20/200 OD
20/60 OS
280
EOM normal
+APD OS
IOP 16/19
Gonio: normal
Anterior Segment Normal
281
282
283
284
285
286
287
Plan
Consult Neurology
Lumbar Puncture
Consider second round of corticosteroid
288
2 months later...
Untreated
20/200
20/25
289
290
291
292
Diagnosis - Atypical Optic Neuritis
Normal LP, MRI, no confirmation of Lyme
Treatment - help photophobia
293
What about Multiple Sclerosis?
294
15 year data from ONTT
Normal MRI -> risk around 25%
>1 lesions on MRI -> risk around 75%
295
Patient 19
46 year old black female
Routine checkup
Blur at distance
Headache
296
Patient
-3.00 sphere 20/20
Balance CF
"I've never seen good out of my left eye"
297
Patient
Anterior segment normal
Posterior segment normal OD
Myopic degeneration OS
Tilted, myopic nerve OS - ? Pallor OS
298
Patient
Unsure why vision bad
Attributed to old injury
Nothing appears treatable
Refer to Neurology for headache
299
Patient300
301
Follow-up
KERATOMETRY
46.5/47 OD AND OS
AXIAL LENGTH
23.5 MM OD
31.0 MM OS
302
Follow-upAUTOREFRACTION
-2.75 SPHERE
-21.00 SPHERE
REFRACTION
-2.75 SPHERE 20/20
-20.00 SPHERE 20/800-
303
Follow-up
Myopic Degeneration and Amblyopia
Posterior Staphyloma
304
Staphyloma
In womb or at birth
Thinning of scleral wall
Protrusion of uvea
305
Staphyloma
No treatment
No known systemic cause
306